Intervention
Pyrazinamide
ClinicalTrials.gov intervention label
Clinical trials
11 shownA Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)NCT07595042 · 2026-10-30
NOT_YET_RECRUITINGSafety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)NCT04930744 · 2022-03-04
COMPLETEDClofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyNCT04311502 · 2021-11-05
TERMINATEDRifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVNCT01601626 · 2013-07-13
TERMINATEDTuberculosis Treatment Shortening TrialNCT00130247 · 2002-04-08
COMPLETEDThe Treatment of Tuberculosis in HIV-Infected PatientsNCT00001033
COMPLETEDA Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.NCT00000796
COMPLETEDProphylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionNCT00000636
COMPLETEDPreventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous InfectionNCT00000638
COMPLETEDMetabolism of Antituberculosis Drugs in HIV-Infected Persons With TuberculosisNCT00000950
COMPLETEDEffectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With TuberculosisNCT00004736
COMPLETEDCommon conditions
Leading sponsors
Trial status mix
COMPLETED8
TERMINATED2
NOT_YET_RECRUITING1
Phase mix
NA4
PHASE24
PHASE32
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.